跳至主要内容
临床试验/NCT02074124
NCT02074124已完成不适用

Abdominal Tissue Perfusion Changes in Esophageal and Gastric Cancer During Adenosine Vasodilation Measured With Computed Tomography (CT) Perfusion

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Change in arterial flow during adenosine vasodilation test (CT perfusion parameter)

研究概览

简要总结

The aim of this study was to investigate changes in abdominal tissue perfusion during adenosine vasodilation. Our hypotheses were that CT perfusion measurements are altered by changes in the circulatory system mediated by adenosine, and a more differentiated assessment of the circulatory capacity of abdominal tumours could be achieved by sequential rest and adenosine vasodilation CT perfusion measurements.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Tumour larger than 1.5 cm on diagnostic CT
  • Normal serum creatinine
  • Age above 18
  • Informed written and oral consent.

排除标准

  • Contrast allergy or contrast induced nephropathy
  • BMI > 40
  • Asthma or Chronic Obstructive Lung Disease
  • Heart failure (NYHA III+)
  • Heart conduction disorder
  • Atrial fibrillation
  • 2nd/3rd Heart block
  • Long QT syndrome
  • Wolf Parkinson White Syndrome
  • Moderate / severe aortic stenosis
  • Haemodynamic contraindications for adenosine, systolic pressure below 90

结局指标

主要结局

Change in arterial flow during adenosine vasodilation test (CT perfusion parameter)

时间窗: 0 min and 15 min

次要结局

  • Change in Blood pressure during adenosine vasodilation test(0 min and 15 min)
  • Change in Heart rate during adenosine vasodilation test(0 min and 15 min)
  • Change in Area under arterial input curve during adenosine vasodilation test(0 min and 15 min)
  • Change in Blood volume (CT perfusion parameter) during adenosine vasodilation test(0 min and 15 min)
  • Change in Permeability (CT perfusion parameter) during adenosine vasodilation test.(0 min and 15 min)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Martin Lundsgaard Hansen

MD

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验